Matthew R. Kane, President and CEO at PRECISION BIOSCIENCES INC (DTIL), sold 39,826 shares at $13.74 ($543K) on 2021-01-25, disclosed to the SEC on 2021-01-26.
Open-market sale of $543k DTIL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.53 | 10,218 | $138K | 25.5% |
| 2 | $13.53 | 10,218 | $138K | 25.5% |
| 3 | $13.74 | 9,695 | $133K | 24.5% |
| 4 | $13.74 | 9,695 | $133K | 24.5% |
| Total | $13.63 avg | 39,826 | $543K | 100% |
| Filing → |
| DTIL | SELL | 2021-04-14 | $169K | — | Filing → |
| DTIL | SELL | 2021-04-12 | $260K | — | Filing → |
| DTIL | SELL | 2021-03-16 | $221K | — | Filing → |